MedTrace Logo

Uric Acid Study in Healthy Male Volunteers

NCT00738842 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2010-12-03

No results posted yet for this study

Summary

This study is being conducted to examine the effect of AZD6140 on the levels of certain chemicals in subjects' blood and urine.

Conditions

Interventions

DRUG

AZD6140

Oral tablets taken bid for 5 days

DRUG

Placebo to match AZD6140

Oral tablets taken bid for 5 days

Sponsors & Collaborators

Principal Investigators

  • Kathleen Butler, MD · AstraZeneca

  • Stuart Harris, MD · SeaView Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-07-31
Completion
2008-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00738842 on ClinicalTrials.gov